Drug Shortage Report for TEVA-PANTOPRAZOLE MAGNESIUM

Last updated on 2019-04-11 History
Report ID 59708
Drug Identification Number 02440628
Brand name TEVA-PANTOPRAZOLE MAGNESIUM
Common or Proper name PANTOPRAZOLE MAGNESIUM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-07-15
Estimated end date 2019-03-30
Actual end date 2019-03-30
Shortage status Resolved
Updated date 2019-04-11
Company comments Product being allocated monthly but cannot support additional demand.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-04-11 French Compare
v7 2019-04-11 English Compare
v6 2019-03-12 French Compare
v5 2019-03-12 English Compare
v4 2019-01-03 French Compare
v3 2019-01-03 English Compare
v2 2018-08-31 French Compare
v1 2018-08-31 English Compare